Virtu Financial LLC - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 66 filers reported holding VYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$14,000
-44.0%
61,464
-5.2%
0.00%
-50.0%
Q2 2022$25,000
+56.2%
64,838
+163.6%
0.00%
+100.0%
Q1 2022$16,000
-91.1%
24,601
-86.0%
0.00%
-94.4%
Q4 2021$179,000
+18.5%
175,278
+61.8%
0.02%
+38.5%
Q3 2021$151,000
+62.4%
108,319
+696.6%
0.01%
+85.7%
Q1 2021$93,00013,5980.01%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,670,000$1,736,0000.60%
GSA CAPITAL PARTNERS LLP 236,292$154,0000.02%
BAILARD, INC. 139,381$91,0000.00%
Tekla Capital Management LLC 135,395$88,0000.00%
DELTEC ASSET MANAGEMENT LLC 30,000$20,0000.00%
TOBIAS FINANCIAL ADVISORS, INC. 11,000$7,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$41,0000.00%
Virtu Financial LLC 24,601$16,0000.00%
Renaissance Technologies 965,098$627,0000.00%
CSS LLC/IL 25,264$16,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders